Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History MDWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics MDWD

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Mediwound Ltd

MDWD
Current price
20.00 USD -0.02 USD (-0.10%)
Last closed 20.01 USD
ISIN IL0011316309
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 232 342 208 USD
Yield for 12 month -1.62 %
1Y
3Y
5Y
10Y
15Y
MDWD
21.11.2021 - 28.11.2021

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel. Address: 42 Hayarkon Street, Yavne, Israel, 8122745

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

30.67 USD

P/E Ratio

Dividend Yield

Financials MDWD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures MDWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+20 222 000 USD

Last Year

+18 686 000 USD

Current Quarter

+3 955 000 USD

Last Quarter

+5 840 000 USD

Current Year

+2 634 000 USD

Last Year

+3 578 000 USD

Current Quarter

+738 000 USD

Last Quarter

+903 000 USD
EBITDA -20 082 000 USD
Operating Margin TTM -132.11 %
Price to Earnings
Return On Assets TTM -19.88 %
PEG Ratio -0.070
Return On Equity TTM -77.92 %
Wall Street Target Price 30.67 USD
Revenue TTM 19 213 000 USD
Book Value 2.90 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -20.30 %
Dividend Yield
Gross Profit TTM 2 765 000 USD
Earnings per share -2.05 USD
Diluted Eps TTM -2.05 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -110.45 %

Stock Valuation MDWD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 9.98
Price Sales TTM 12.09
Enterprise Value EBITDA -6.32
Price Book MRQ 7.15

Technical Indicators MDWD

For 52 Weeks

14.14 USD 22.51 USD
50 Day MA 19.82 USD
Shares Short Prior Month 916 741
200 Day MA 18.02 USD
Short Ratio 10.88
Shares Short 889 182
Short Percent 9.96 %